Apremilast For The Treatment Of Behcet's Syndrome: A Phase II Randomized, Placebo-Controlled, Double-Blind Study
dc.contributor.author | Hatemi, Gulen | |
dc.contributor.author | Melikoglu, Melike | |
dc.contributor.author | Tunc, Recep | |
dc.contributor.author | Korkmaz, Cengiz | |
dc.contributor.author | Ozturk, Banu Turgut | |
dc.contributor.author | Mat, Cem | |
dc.contributor.author | Merkel, Peter A. | |
dc.date.accessioned | 2020-03-26T18:41:08Z | |
dc.date.available | 2020-03-26T18:41:08Z | |
dc.date.issued | 2013 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description | 77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals -- OCT 25-30, 2013 -- San Diego, CA | en_US |
dc.description.abstract | [Abstract not Available] | en_US |
dc.description.sponsorship | Amer Coll Rheumatol, Assoc Rheumatol Hlth Profess | en_US |
dc.identifier.endpage | S322 | en_US |
dc.identifier.issn | 0004-3591 | en_US |
dc.identifier.issn | 1529-0131 | en_US |
dc.identifier.startpage | S322 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/29236 | |
dc.identifier.volume | 65 | en_US |
dc.identifier.wos | WOS:000325359202266 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | WILEY-BLACKWELL | en_US |
dc.relation.ispartof | ARTHRITIS AND RHEUMATISM | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.title | Apremilast For The Treatment Of Behcet's Syndrome: A Phase II Randomized, Placebo-Controlled, Double-Blind Study | en_US |
dc.type | Conference Object | en_US |